These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23116251)

  • 1. Advances in drug development for acute migraine.
    Cady RJ; Shade CL; Cady RK
    Drugs; 2012 Dec; 72(17):2187-205. PubMed ID: 23116251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of acute attacks of migraine and prevention of migraine headache.
    Snow V; Weiss K; Wall EM; Mottur-Pilson C; ;
    Ann Intern Med; 2002 Nov; 137(10):840-9. PubMed ID: 12435222
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G; Rolando S; De Lorenzo C; Benedetto C
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute management of migraine.
    Chowdhury D
    J Assoc Physicians India; 2010 Apr; 58 Suppl():21-5. PubMed ID: 21049703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute migraine therapy: recent evidence from randomized comparative trials.
    Mett A; Tfelt-Hansen P
    Curr Opin Neurol; 2008 Jun; 21(3):331-7. PubMed ID: 18451718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update.
    Tfelt-Hansen P
    Curr Clin Pharmacol; 2012 Feb; 7(1):66-72. PubMed ID: 22299771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summaries for patients. Guidelines for the treatment and prevention of migraine headaches.
    Ann Intern Med; 2002 Nov; 137(10):I50. PubMed ID: 12435232
    [No Abstract]   [Full Text] [Related]  

  • 9. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatment of migraine. Comparison of guidelines.
    Schuurmans A; van Weel C
    Can Fam Physician; 2005 Jun; 51(6):838-43. PubMed ID: 15986940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
    Misra UK; Kalita J; Yadav RK
    J Headache Pain; 2007 Jun; 8(3):175-9. PubMed ID: 17563841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological strategies to treat attacks of episodic migraine in adults.
    Tfelt-Hansen P
    Expert Opin Pharmacother; 2021 Feb; 22(3):305-316. PubMed ID: 33003955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Migraine Treatment.
    Becker WJ
    Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):953-72. PubMed ID: 26252584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study.
    Stronks DL; Tulen JH; Bussmann HB; Mulder LJ; Passchier J
    Headache; 2003 Sep; 43(8):845-52. PubMed ID: 12940805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine in the triptan era: progresses achieved, lessons learned and future developments.
    Bigal ME; Krymchantowski AV; Ho T
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):559-69. PubMed ID: 19623468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the effect of triptans in migraine.
    Tfelt-Hansen P; Olesen J
    Lancet; 2006 Oct; 368(9544):1313-4. PubMed ID: 17046449
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual triptan selection in migraine attack therapy.
    Belvís R; Pagonabarraga J; Kulisevsky J
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):70-81. PubMed ID: 19149716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.